Scarica l'app Stockscreener
2.62
0.76%
-0.02
Dopo l'orario di chiusura:
2.61
-0.01
-0.38%
Precedente Chiudi:
$2.64
Aprire:
$2.6
Volume 24 ore:
33,956
Relative Volume:
0.01
Capitalizzazione di mercato:
$45.25M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-4.73%
1M Prestazione:
+0.00%
6M Prestazione:
-34.34%
1 anno Prestazione:
-21.79%
Intervallo 1D:
$2.56
$2.709
Intervallo di 1 settimana:
$2.56
$2.77
Portata 52W:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Nome
Mural Oncology Plc
Settore
Industria
Telefono
353 1 905 8020
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Confronta MURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.62 | 47.49M | 0 | 0 | 0 | 0.00 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-04 | Iniziato | Morgan Stanley | Overweight |
Mural Oncology Plc Borsa (MURA) Ultime notizie
Form 8.3Mural Oncology plc - Business Wire
BlackRock discloses stake in Mural Oncology By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology - Investing.com Australia
Goldman Sachs adjusts positions in Mural Oncology By Investing.com - Investing.com South Africa
Goldman Sachs adjusts positions in Mural Oncology - Investing.com Australia
Goldman Sachs reports trading in Mural Oncology shares By Investing.com - Investing.com South Africa
Mural Oncology Announces Number of Relevant Securities in Issue - The Manila Times
Mural Oncology Discloses Share Count Under Irish Takeover Rules: What's Behind This Move? - Stock Titan
Goldman Sachs reports trading in Mural Oncology shares - Investing.com Australia
Mural Oncology plc (NASDAQ:MURA) Shares Sold by Price T Rowe Associates Inc. MD - Defense World
Goldman Sachs reveals stake in biopharmaceutical firm Mural Oncology - Dimsum Daily
Goldman Sachs discloses stake in Mural Oncology By Investing.com - Investing.com South Africa
Goldman Sachs discloses stake in biopharmaceutical firm Mural Oncology - Dimsum Daily
Goldman Sachs discloses stake in Mural Oncology - Investing.com
Goldman Sachs reports dealings in Mural Oncology shares By Investing.com - Investing.com Nigeria
Goldman Sachs reports dealings in Mural Oncology shares - Investing.com
BlackRock discloses stake in Mural Oncology plc By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology plc - Investing.com
BlackRock reports stake in Mural Oncology By Investing.com - Investing.com Canada
BlackRock reports stake in Mural Oncology - Investing.com
56,176 Shares in Mural Oncology plc (NASDAQ:MURA) Purchased by Raymond James Financial Inc. - Defense World
Layoff Tracker: IGM Axes 80% of Workforce - BioSpace
Mural Oncology Plc Azioni (MURA) Dati Finanziari
Non sono disponibili dati finanziari per Mural Oncology Plc (MURA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.89%
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):